Futura Medical PLC
05 February 2004
Press Release 5 February 2004
Futura Medical exercises Second Call Option
Futura Medical plc ('Futura'), the AIM-listed pharmaceutical and medical device
group that develops innovative products for the sexual healthcare market, has
exercised the second of three call options under the subscription agreement with
Long Fleet Systems Inc signed in June 2003.
The exercise terms have been varied slightly and settlement will be in several
tranches during February 2004.
Under this second option, the sum of £800,000 (£780,000 net of costs) will be
raised by the issue of 1,125,175 new ordinary shares of 0.2 pence each at a
price of 71.10 pence per share. This is at the agreed 10 per cent discount to
the recent average share price in accordance with the terms of the subscription
agreement.
As part of this, today the sum of £263,070 has been raised by the issue of
370,000 shares and Application has been made for the new shares being issued to
be admitted to trading on AIM. The new shares will rank pari passu with
existing ordinary shares and dealings are expected to commence at 8.00am on 10
February 2004.
A further 755,175 shares remain to be issued under this second option in
accordance with the varied settlement terms.
Upon completion of all tranches, warrants will be issued over 250,000 ordinary
shares exercisable at any time over the next 12 months at an exercise price of
71.10 pence per ordinary share in accordance with the subscription agreement
with Long Fleet Systems Inc.
For further information:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 845 670
mailto:james.barder@futuramedical.co.uk www.futuramedical.co.uk
Media enquiries:
Bankside
Peter Curtain / Alex Tweed Tel: +44 (0) 20 7444 4140
mailto:alexandra.tweed@bankside.com www.bankside.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.